For example, spinal muscular atrophy (SMA) can be treated using adeno-associated virus (AAV)-mediated gene replacement to express the functional SMN1 gene, as demonstrated by the therapeutic onasemnogene abeparvovec-xioi (Alves et al., 2024). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.